Chemoprevention of colon cancer by iNOS-selective inhibitors

NB Janakiram, CV Rao - Onco Therapeutics, 2012 - dl.begellhouse.com
Nitric oxide (NO) is a short-lived pleiotropic regulator and is required for numerous
pathophysiological functions, including macrophage-mediated immunity and cancer. It is a …

iNOS-selective inhibitors for cancer prevention: promise and progress

NB Janakiram, CV Rao - Future medicinal chemistry, 2012 - Taylor & Francis
Nitric oxide (NO) is involved in various physiological functions and its role in tumorigenesis
has been well studied. A large majority of human and experimental tumors appear to …

Nitric oxide signaling in colon cancer chemoprevention

CV Rao - … Research/Fundamental and Molecular Mechanisms of …, 2004 - Elsevier
Nitric oxide (NO) is a pleiotrophic regulator, pivotal to numerous biological processes,
including vasodilation, neurotransmission, and macrophage-mediated immunity. The highly …

COX‐2 and iNOS, good targets for chemoprevention of colon cancer

K Watanabe, T Kawamori, S Nakatsugi… - Biofactors, 2000 - Wiley Online Library
Abstract Cyclooxygenase (COX)‐2 has been suggested to play an important role in colon
carcinogenesis. We found that the COX‐2 selective inhibitor, nimesulide, reduces …

Novel agents for cancer prevention based on nitric oxide

B Rigas - Biochemical Society Transactions, 2007 - portlandpress.com
NO (nitric oxide) biology has provided the impetus for the development of anticancer agents
based on their ability to release NO. NO-NSAIDs (NO-donating non-steroidal anti …

Nitric oxide (NO) and NO synthases (NOS)-based targeted therapy for colon cancer

H Wang, L Wang, Z Xie, S Zhou, Y Li, Y Zhou, M Sun - Cancers, 2020 - mdpi.com
Colorectal cancer (CRC) is one of the most lethal malignancies worldwide and CRC therapy
remains unsatisfactory. In recent decades, nitric oxide (NO)—a free-radical gas—plus its …

Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs …

JL Williams, S Borgo, I Hasan, E Castillo, F Traganos… - Cancer Research, 2001 - AACR
Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NO-NSAIDs), consisting of a
known nonsteroidal anti-inflammatory drug (NSAID) and a nitric oxide (NO)-releasing group …

Inducible nitric oxide synthase in the carcinogenesis of gastrointestinal cancers

GA de Oliveira, RYS Cheng, LA Ridnour… - Antioxidants & redox …, 2017 - liebertpub.com
Significance: Gastrointestinal (GI) cancer taken together constitutes one of the most common
cancers worldwide with a broad range of etiological mechanisms. In this review, we have …

Small molecule inhibitors and stimulators of inducible nitric oxide synthase in cancer cells from natural origin (phytochemicals, marine compounds, antibiotics)

N Özenver, T Efferth - Biochemical Pharmacology, 2020 - Elsevier
Nitric oxide synthases (NOS) are a family of isoforms, which generate nitric oxide (NO). NO
is one of the smallest molecules in nature and acts mainly as a potent vasodilator. It …

[HTML][HTML] The potential role of nitric oxide in halting cancer progression through chemoprevention

H Vahora, MA Khan, U Alalami… - Journal of cancer …, 2016 - ncbi.nlm.nih.gov
Nitric oxide (NO) in general plays a beneficial physiological role as a vasorelaxant and the
role of NO is decided by its concentration present in physiological environments. NO either …